Bazylewicz, M.; Zajkowska, M.; Gudowska-Sawczuk, M.; Kułakowski, R.; Mroczko, J.; Mirowska-Guzel, D.; Kulikowska-Łoś, J.; Czarnowska, A.; Mroczko, B.; Kochanowicz, J.;
et al. Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate. Biomedicines 2025, 13, 153.
https://doi.org/10.3390/biomedicines13010153
AMA Style
Bazylewicz M, Zajkowska M, Gudowska-Sawczuk M, Kułakowski R, Mroczko J, Mirowska-Guzel D, Kulikowska-Łoś J, Czarnowska A, Mroczko B, Kochanowicz J,
et al. Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate. Biomedicines. 2025; 13(1):153.
https://doi.org/10.3390/biomedicines13010153
Chicago/Turabian Style
Bazylewicz, Marcin, Monika Zajkowska, Monika Gudowska-Sawczuk, Rafał Kułakowski, Jan Mroczko, Dagmara Mirowska-Guzel, Joanna Kulikowska-Łoś, Agata Czarnowska, Barbara Mroczko, Jan Kochanowicz,
and et al. 2025. "Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate" Biomedicines 13, no. 1: 153.
https://doi.org/10.3390/biomedicines13010153
APA Style
Bazylewicz, M., Zajkowska, M., Gudowska-Sawczuk, M., Kułakowski, R., Mroczko, J., Mirowska-Guzel, D., Kulikowska-Łoś, J., Czarnowska, A., Mroczko, B., Kochanowicz, J., & Kułakowska, A.
(2025). Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate. Biomedicines, 13(1), 153.
https://doi.org/10.3390/biomedicines13010153
